Ancient wisdom meets modern tech: 10,000-person trial tests online diabetes care
NCT ID NCT07265037
First seen Jan 05, 2026 · Last updated Jun 21, 2026 · Updated 26 times
Summary
This study will enroll 10,000 people with type 2 diabetes to test a new digital platform that blends traditional Chinese medicine (TCM) with Western medicine. Participants use connected devices, a mobile app, and cloud services to receive personalized care and automated follow-ups from a team of experts. The goal is to see if this combined online-offline approach can improve blood sugar control and reduce complications over six months.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIGITAL HEALTH are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Shanxi Bethune Hospital
RECRUITINGTaiyuan, Shanxi, 030000, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Integrated TCM-Western Medicine Intelligent Diabetes Management Platform (digital health platform with connected devices, app, and cloud services)
What this could lead to
If successful, this could provide a practical, low-cost way for people with diabetes to manage their condition long-distance, potentially reducing complications and improving quality of life.
What could go wrong
This is a large but early-stage study testing a complex intervention; results may vary widely, and the digital platform may not work equally well for all patients. It is not a cure and requires ongoing self-management.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.